Sidvim LifeSciences Private Limited

       Contents A brief analysis of USDMFs filed by Indian companies in July 2020.  General information.  Dr Reddy's to launch 30 more products in US market this year  FDA clarifies reference-listed drugs, other ANDA terms in final guidance.  China adopts revised patent law with Hatch-Waxman-like incentives for innovative drugs  Intellectual Property.  NL – NOVARTIS V. MYLAN / DEFERASIROX (Exjade)     A brief analysis of USDMFs filed by Indian companies in July 2020 DMF list is updated every quarter at USFDA website. It is updated till September 2020 for the months, July, August and September.  This week, we have analyzed DMFs filed by Indian companies in July 2020. In subsequent Newsletters, we will cover the other months. In July 2020, 50 DMFs were filed in total, out of which 25 DMFs were filed by Indian companies. Century Pharmaceuticals filed 5 DMFs, Biocon, Cadila Pharmaceutical, Cadila Healthcare file...

  Contents Very brief analysis of Exports of Cadila. General information Change in Data Exclusivity for Pharmaceutical Products in the United Arab Emirates Nigerian drug regulator blacklists Gujarat pharma company for ‘substandard’ antibiotics Intellectual Property Very brief analysis of Exports of Cadila. Last few weeks we are following Cadila Healthcare. We analysed their patent portfolio. We studied their import data; we reported about their probable development pipeline. Today we are analysing exports of   Cadila and arrived at some very interesting finding. To start with, few graphs about commercial information about exports Top oversees customers of Cadila Top export countries by volume Top 25 Exports of Cadila: 1.       Nebivolol and Amlodipine are among top exports. 2.       Most of top 10 exports is to trader in Ireland. 3.       US is top export by Value...